ReviewImmunotherapy2015
Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.
Amer Assal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it
ReviewImmunotherapy2015
Amer Assal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.